Monty is extremely sensitive to the side effects of Prednisone (see Cushing’s syndrome), but it is also the only drug proven to keep GME at bay. It’s a delicate balance of disease treatment and symptom management we’ve been through before and will get through again.
Today’s neurologist checkup went well with the CBC panel coming back normal, so he had another Cytosar treatment. We’ve started a new daily supplement called Denamarin to help support his liver functionality and health with all of the medications he receives daily, and have introduced Leflunomide in the hopes of supplementing and eventually replacing the Prednisone that gives him such a hard time. While Leflunomide has not yet gained widespread acceptance as a GME treatment, Dr Allen Sisson (one of the leading doctors in the research and treatment of GME) has seen remission rates of up to 90% at 1.5 years when including the drug in long term treatment protocols. Additionally we decided to see if we can drop the daily antibiotic without any new UTI or hot spot issues in an effort to reduce the daily med load.